Shaping the future of cancer treatment

Keeping people with cancer strong

Keeping people with cancer strong

Our research has found a way to fight the muscle-wasting condition, cachexia.

Landing feature A

Drag an item from the library above. Create a new item if your library is empty.

Cachexia, a muscle-wasting condition, is a major side effect of cancer. Cachexia causes muscle atrophy, weakness, fatigue and anaemia. It can make cancer patients too weak to continue treatment and enjoy time with their family and friends.

But a team of La Trobe researchers have made a breakthrough. After almost eight years of research, they’ve found a cause of cachexia. Now, they’re working on an antibody.

‘I don’t tend to throw around the term "world-first" – but this is a world-first discovery,’ says co-lead researcher Dr Amelia Johnston.

The team's discovery means a person with cancer will stay stronger for longer, improving their ability to fight the disease.

Angela Mellerick, a cancer oncology nurse at ONCRI and La Trobe alumna, talks in our video about her experience with cancer patients and her hopes that our research will improve their lives.

Our fight against cachexia

La Trobe's Dr Amelia Johnston tells the story of her team's groundbreaking research.

Find out more

Study science at La Trobe

From undergraduate to postgraduate, we're recognised for world-class research.

Learn more

La Trobe Institute for Molecular Science

LIMS is committed to solving global problems and improving the welfare of human societies.

Discover more

The future of cancer care

We're working on an antibody that could help the fight against cancer.

Watch video